| Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection HK Okur, K Yalcin, C Tastan, S Demir, B Yurtsever, GS Karakus, ... New microbes and new infections 37, 100756, 2020 | 47 | 2020 |
| Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates G Sir Karakus, C Tastan, D Dilek Kancagi, B Yurtsever, G Tumentemur, ... Scientific reports 11 (1), 5804, 2021 | 18* | 2021 |
| Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61. 3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice RD Turan, C Tastan, D Dilek Kancagi, B Yurtsever, G Sir Karakus, S Ozer, ... Scientific reports 11 (1), 15799, 2021 | 12 | 2021 |
| Preclinical assessment of efficacy and safety analysis of CAR-T cells (ISIKOK-19) targeting CD19-expressing B-cells for the first Turkish academic clinical trial with relapsed … C Taştan, DD Kançağı, RD Turan, B Yurtsever, D Çakırsoy, S Abanuz, ... Turkish Journal of Hematology 37 (4), 234, 2020 | 9 | 2020 |
| Preliminary report of the academic CAR-T (ISIKOK-19) cell clinical trial in Turkey: Characterization of product and outcomes of clinical application E Erdoğan, K Yalçın, C Hemşinlioğlu, A Sezgin, U Seyis, DD Kancağı, ... Turkish Journal of Hematology 39 (3), 206, 2022 | 5 | 2022 |
| Suprachoroidal spheroidal mesenchymal stem cell implantation in retinitis pigmentosa: Clinical results of 6 months follow-up B Özkan, B Yılmaz Tuğan, C Hemşinlioğlu, G Sır Karakuş, Ö Şahin, ... Stem Cell Research & Therapy 14 (1), 252, 2023 | 2 | 2023 |
| In Vitro FVIII-Encoding Transgenic Mesenchymal Stem Cells Maintain Successful Coagulation in FVIII-Deficient Plasma Mimicking Hemophilia A C Hemşinlioğlu, ES Aslan, C Taştan, D Çakırsoy, RD Turan, U Seyis, ... Turkish Journal of Hematology 40 (2), 118, 2023 | 2 | 2023 |
| The effectiveness of ACB-IP 1.0 universal pathogen free concentrated cocktail convalescent plasma in COVID-19 infection C Hemsinlioglu, NB Pelit, K Yalcin, OS Gunaydın, NO Sahin, ES Karagacli, ... medRxiv, 2021.03. 05.21251413, 2021 | 1 | 2021 |
| Mesenchymal stromal cell therapy for critically ill patients With COVID-19 K Yalcin, C Hemsinlioglu, R Zengin, M Sonmezoglu, R Hakan, ... JMIR Prepr 20206, 2020 | 1 | 2020 |
| Successfull management of post-car-t cell cold aglutinin mediated refractory autoimmune hemolytic anemia with daratumumab E Erdogan, MU Menguc, K Yalcin, C Hemsinlioglu, E Ovali, S Ratip BONE MARROW TRANSPLANTATION 57 (SUPPL 1), 145-146, 2022 | | 2022 |
| Türkiye Akademik CAR-T Hücre (ISIKOK-19) Klinik Çalışması Ön Raporu: Ürün Karakterizasyonu ve Klinik Uygulama Sonuçları E Erdoğan, K Yalçın, C Hemşinlioğlu, A Sezgin, U Seyis, DD Kancağı, ... Turkish Journal of Hematology 39 (3), 206-210, 2022 | | 2022 |
| THE EFFECTIVENESS OF ACB-IP 1.0 UNIVERSAL PATHOGEN FREE CONCENTRATED COCKTAIL CONVALESCENT PLASMA IN COVID-19 INFECTION (preprint) C Hemsinlioglu, NB Pelit, K Yalcin, OS Gunaydin, NO Sahin, ES Karagacli, ... | | 2021 |
| ISIKOK-19 CAR-T Hücre tedavisi Faz I/II Çalışması Ön Sonuçları E Kızılkılıç, A Akıncı, A Sezgin, C Hemşinlioğlu, F Demir Yenigürbüz, ... | | |
Ercüment OvalıProfessorVerified email at superonline.com
